CS logo
small CS logo
Instituto Nacional de Enfermedades Neoplasicas

Lima, Peru
Hospital in the Surquillo
Av. Angamos 2520, Surquillo 15038

About Instituto Nacional de Enfermedades Neoplasicas


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
20
National Cancer Institute (NCI)
10
ETOP IBCSG Partners Foundation
6
Eastern Cooperative Oncology Group
5
Alliance for Clinical Trials in Oncology
3
European Organisation for Research and Treatment of Cancer - EORTC
3
M.D. Anderson Cancer Center
3
ECOG-ACRIN Cancer Research Group
2
EMD Serono Research & Development Institute, Inc.
2
International Atomic Energy Agency
2
SWOG Cancer Research Network
2
Total Rows: 26

Clinical Trials at Instituto Nacional de Enfermedades Neoplasicas


During the past decade, Instituto Nacional de Enfermedades Neoplasicas conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 27 clinical trials were completed, i.e. on average, 122.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years5522115533551155444466441100Started TrialsCompleted Trails201520162017201820192020202102468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
1994-09-01
2006-07-01
Completed
270
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
1994-12-01
2005-08-01
Completed
66
Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
1995-10-01
1998-09-01
Terminated
13
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
1996-01-01
2006-08-01
Completed
135
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
1997-03-01
2012-01-01
Completed
212
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
1998-07-01
2004-01-01
Terminated
7
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
1998-07-01
Completed
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
1999-06-01
Completed
400

Rows per page:

1–73 of 73

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto Nacional de Enfermedades Neoplasicas" #1 sponsor was "Hoffmann-La Roche" with 20 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "ETOP IBCSG Partners Foundation" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored and "Alliance for Clinical Trials in Oncology" with 5 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Enfermedades Neoplasicas" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 52 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 20Hoffmann-La Roche: 20National CancerInstitute (NCI): 10National CancerInstitute (NCI): 10ETOP IBCSG PartnersFoundation: 6ETOP IBCSG PartnersFoundation: 6Eastern CooperativeOncology Group: 5Eastern CooperativeOncology Group: 5Alliance for ClinicalTrials in Oncology: 3Alliance for ClinicalTrials in Oncology: 3European Organisationfor Research andTreatment of Cancer -EORTC: 3European Organisationfor Research andTreatment of Cancer -EORTC: 3M.D. Anderson Cancer Center: 3M.D. Anderson Cancer Center: 3ECOG-ACRIN CancerResearch Group: 2ECOG-ACRIN CancerResearch Group: 2EMD Serono Research &Development Institute,Inc.: 2EMD Serono Research &Development Institute,Inc.: 2International AtomicEnergy Agency: 2International AtomicEnergy Agency: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 21National CancerInstitute (NCI): 21Eastern CooperativeOncology Group: 7Eastern CooperativeOncology Group: 7Cancer and LeukemiaGroup B: 6Cancer and LeukemiaGroup B: 6Breast International Group: 5Breast International Group: 5SWOG Cancer ResearchNetwork: 5SWOG Cancer ResearchNetwork: 5NCIC Clinical Trials Group: 3NCIC Clinical Trials Group: 3North Central CancerTreatment Group: 3North Central CancerTreatment Group: 3Genentech, Inc.: 2Genentech, Inc.: 2Latin AmericanCooperative OncologyGroup: 2Latin AmericanCooperative OncologyGroup: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2

Clinical Trials Conditions at Instituto Nacional de Enfermedades Neoplasicas


According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Enfermedades Neoplasicas" are "Breast Cancer" (18 trials), "Breast Adenocarcinoma" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Breast Neoplasms" (2 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Instituto Nacional de Enfermedades Neoplasicas" in a lesser frequency.

Clinical Trials Intervention Types at Instituto Nacional de Enfermedades Neoplasicas


Most popular intervention types in "Instituto Nacional de Enfermedades Neoplasicas" are "Drug" (55 trials), "Other" (12 trials), "Biological" (11 trials), "Procedure" (10 trials) and "Radiation" (8 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (12 trials), "Atezolizumab" (10 trials), "Bevacizumab" (10 trials), "Cyclophosphamide" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto Nacional de Enfermedades Neoplasicas


The vast majority of trials in "Instituto Nacional de Enfermedades Neoplasicas" are 52 trials for "All" genders, 18 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Instituto Nacional de Enfermedades Neoplasicas


Currently, there are NaN active trials in "Instituto Nacional de Enfermedades Neoplasicas". undefined are not yet recruiting, 6 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Instituto Nacional de Enfermedades Neoplasicas, undefined suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Nacional de Enfermedades Neoplasicas, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 47Phase 3: 47Phase 2: 13Phase 2: 13Not Applicable: 7Not Applicable: 7Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 38Completed: 38Active, not recruiting: 18Active, not recruiting: 18Terminated: 9Terminated: 9Recruiting: 6Recruiting: 6Unknown status: 2Unknown status: 2